Surgical Glaucoma Adoption & Growth Leader

Iantrek; United States; Remote; USD 120,000 - 180,000; Full time

Job summary

Iantrek is expanding its commercial team with a Surgical Glaucoma Manager to drive adoption of AlloFlo Uveo and C.Rex across territories. You will build comprehensive business plans, engage surgeons and staff, and work with ASC/hospital administrations to secure approvals.

The role requires 5+ years in ophthalmic sales, a proven track record, and strong communication and relationship-building skills. Travel within territory and nationwide is expected.

Qualifications

• 5+ years in ophthalmic sales.
• Proven track record of achieving sales targets.
• Strong communication and relationship-building skills.
• Willingness to travel within territory and nationwide.

Responsibilities

• Drive adoption of AlloFlo Uveo and C.Rex across assigned territory.
• Develop and execute comprehensive business plans aligned with market dynamics.
• Understand market access and engage ophthalmic surgeons and staff.
• Build physician advocacy within ASCs and academic training programs.
• Collaborate with ASC/hospital administration to gain product approvals.
• Represent Iantrek at congresses, wet labs, and local events.
• Partner with clinical, marketing, and training teams to onboard surgeons.
• Maintain CRM with accurate, timely records and pipeline visibility.
• Deliver on sales goals reflecting company values: trust, accountability, collaboration.

Skills

ophthalmic sales

medical devices (Surgical Glaucoma)

sales targets

clinical acumen

communication

relationship building

travel willingness

Job description

Iantrek is expanding its commercial team with a Surgical Glaucoma Manager to drive adoption of AlloFlo Uveo and C.Rex across territories. You will build comprehensive business plans, engage surgeons and staff, and work with ASC/hospital administrations to secure approvals.

The role requires 5+ years in ophthalmic sales, a proven track record, and strong communication and relationship-building skills. Travel within territory and nationwide is expected.